NCT06999902Phase 2, phase 3Completed

Double-blind, Randomized Trial of PRAX-628 in Adults With Focal Seizures to Evaluate Efficacy and Safety (POWER1)

Study sponsor: Praxis Precision Medicines

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2026-05-14Actual
Enrollment · participants255Actual
Source updated2026-08-10Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 5 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 230 participants (planned). After: 255 participants (actual).

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: 24 Nov 2025. After: 14 May 2026.

Recruitment status changed

Before: Recruiting. After: Completed.

Check registry source